Back to Journals » Psychology Research and Behavior Management » Volume 17

Survival, Attachment, and Healing: An Evolutionary Lens on Interventions for Trauma-Related Dissociation

Authors Burback L , Forner C , Winkler OK, Al-Shamali HF , Ayoub Y , Paquet J , Verghese M

Received 30 January 2024

Accepted for publication 21 May 2024

Published 18 June 2024 Volume 2024:17 Pages 2403—2431

DOI https://doi.org/10.2147/PRBM.S402456

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 4

Editor who approved publication: Dr Gabriela Topa



Lisa Burback,1,2 Christine Forner,3 Olga Karolina Winkler,1 Huda F Al-Shamali,1 Yahya Ayoub,1 Jacquelyn Paquet,1 Myah Verghese4

1Department of Psychiatry, University of Alberta, Edmonton, Alberta, Canada; 2Neuroscience and Mental Health Institute (NMHI), University of Alberta, Edmonton, Alberta, Canada; 3Associated Counseling, Calgary, Alberta, Canada; 4Department of Neuroscience, University of Alberta, Edmonton, Alberta, Canada

Correspondence: Lisa Burback, Department of Psychiatry, University of Alberta, 4-142A Katz Group Centre for Research, 11315 - 87 Ave NW, Edmonton, AB, T6G 2H5, Canada, Tel +1 780 342 5635, Fax +1 780 342 5230, Email [email protected]

Purpose: Dissociation is a necessary part of our threat response system, common to all animal species, normally temporarily activated under conditions of extreme or inescapable threat. Pathological dissociation, however, continues to occur after the initial threat has passed, in response to reminders or inaccessibility of safety and security. Present across the spectrum of psychiatric diagnoses, recurrent dissociative symptoms are linked to severe trauma exposure, insecure attachment, treatment non-response, and maladaptive coping behaviors such as substance use, suicidality, and self-harm. However, empirical studies testing treatments specific to dissociative processes remain scarce. This narrative review summarizes existing studies and provides theoretical, neurobiological, and evolutionary perspectives on dissociative processes and treatments for pathological dissociation.
Methods: A systematic search of five databases (MEDLINE, EMBASE, APA PsycINFO, CINAHL plus, Scopus) was conducted on April 13, 2023. Peer-reviewed clinical studies with adult participants, assessing intervention effects on dissociative symptoms, were included. Results were thematically analyzed and summarized.
Results: Sixty-nine studies were identified, mainly focused on posttraumatic stress disorder, trauma-exposed populations, and borderline personality disorder. Psychotherapy was studied in 72.5% of studies; other interventions included medications and neurostimulation. The majority reported positive outcomes, despite the heterogeneous spectrum of interventions. However, treatment of dissociative symptoms was the primary objective in only a minority. 
Conclusion: Pathological dissociation is a complex phenomenon involving brain and body systems designed for perceiving and responding to severe threats, requiring an individualized approach. A literature is emerging regarding potentially evidence-based treatments to help those impacted by recurrent dissociative symptoms. When contextualized within a neurobiological and evolutionary perspective, these treatments can be understood as facilitating an internal and/or relational sense of safety, resulting in symptom reduction. Further studies are needed to explore effective treatments for dissociative symptoms.

Keywords: derealization, depersonalization, posttraumatic stress disorder, psychotherapy, psychopharmacology, transcranial magnetic stimulation

Introduction

Overview

For over 130 years, researchers and clinicians have explored the connection between trauma, dissociation, and mental health disorders.1,2 Current research indicates that chronic dissociative symptoms are related to an interplay between genetic vulnerability, attachment disruptions, early life adversity and traumatic experience and are associated with significant mental health burden, including psychiatric comorbidity, disruptions in self-organization, emotional dysregulation, self-injurious behaviors, and suicide attempts.2–10 Furthermore, dissociation is frequently associated with disturbances in cognitive, executive, and interpersonal function, which can adversely impact treatment.11–13 Dissociation is a diagnostic feature of specific, often difficult-to-treat disorders associated with trauma, including dissociative disorders (DD), Borderline Personality Disorder (BPD), the dissociative subtype of Posttraumatic Stress Disorder (PTSD-DS), and complex PTSD (cPTSD).5,14 In treatment, dissociation can hinder emotional engagement and learning;11 however, few treatments exist that specifically focus on alleviating dissociative episodes. For these reasons, there continues to be intense interest in addressing the impact of dissociation.

This review has several aims: 1) to explore trauma-related dissociation through an evolutionary lens, as a neurobiologically driven survival response to severe threat, including relational disruption, 2) to summarize existing empirical studies on interventions impacting dissociation, focusing on depersonalization and derealization, and 3) to place these results within the context of clinical practice and relevance for future research.

A Brief History

Over the last century, dissociation has been categorized and understood as various states and processes, with ongoing debates as to what the term “dissociation” truly entails.2 Normal and pathological, state versus trait, and drug-induced (eg, ketamine) dissociation are examples of such categories, each implying different mechanisms, duration, stability, and relationship to psychopathology. Dissociation is described as a disruption in the usual integration of mental processes, including consciousness, memory, emotions, identity, perception, motor control, body awareness, or behavior, with wide-ranging phenomenology.2,14 For the purpose of this review, a useful distinction is one of normative (ie, non-pathological) versus pathological dissociation. Normative dissociation includes states like absorption, daydreaming, auto-pilot experiences, and hypnosis,15 such as driving home and not remembering details of the journey. Alternatively, pathological dissociation is understood as a sequelae of traumatic or overwhelming experience. In this case, dissociation occurs recurrently long after the original trauma is over, in response to implicit or explicit reminders of those experiences.6,8,9 Such states are accompanied by changes in brain neurochemistry, electricity, and activity patterns, distinct from those accompanying normative dissociation in neutral or safe situations, and serve to avoid the pain of fear and overwhelm.6

Understanding of trauma-related dissociation has significantly evolved since its recognition in the late 1800s. Janet’s observations of individuals diagnosed with hysteria revealed that traumatic experiences could impact thoughts and behaviors, even if not consciously accessible.2,16 For example, a sexual assault survivor may be unable to recall parts of the event, or may be numb to associated emotions and physical sensations. Influenced by this work, dissociation became historically viewed as a defense against intolerable affect or inner conflict.1,2,14,16 Freud, for example, proposed that anxiety provoking material such as traumatic memories could be repressed, preventing conscious awareness.2,16 Thus, 20th century theories of dissociation tended to focus on psychological processes.

Subsequent studies on early life stress and effects of psychological trauma clearly demonstrate, however, impacts on both brain and body. Pathological dissociation, intertwined with attachment and development, is associated with multiple structural and functional brain changes.1,6,7,9,10,17 There is a particular association with prolonged inescapable threat, such as captivity, prolonged torture, child maltreatment or chronic parental misattunement or inconsistency.2,6–9 Such experiences trigger an intense, whole-body survival response, coordinated by the brainstem, involving cognitive, limbic, perceptual, pain, motoric, and hormonal systems that work together to alter information processing and consciousness.6,17 When experienced repeatedly during critical periods of brain development, the induced altered states of consciousness disrupt normal development of memory, cognition, and learning processes, emotional regulation, executive functioning, personality and identity formation, which increases risk for later psychiatric disorders, including PTSD, BPD, and DD.1,2,6,7,10,18,19

Categorizations of Trauma-Related Dissociation

Given the multiform nature of dissociation, multiple clinical classifications and theories on traumatic dissociation exist to aid clinicians. Common categorizations include primary, secondary, and tertiary dissociation,20 state and trait dissociation,21 functional and multiplicity dissociation,22 structural dissociation,23 and phenotypical dissociation.24 These describe distinct but overlapping patterns of symptoms, levels of functioning, and comorbid psychopathology, with more severe forms often encompassing symptoms of milder categories. While a full exposition of these theories is beyond the scope of this review, some general principles are relevant, including differentiating between state-related changes and more complex patterns involving identity self-states.

State dissociation represents transiently altered states of consciousness in response to stress or trauma, occurring during and immediately after a stressor or traumatic reminder. This can be classified as either primary or secondary dissociation. Primary dissociation refers to distressing trauma memory content intruding into conscious awareness, often in visual, olfactory, auditory, or kinesthetic sensory form, such as re-experiencing symptoms of PTSD.20,25 Secondary dissociation, on the other hand, involves distancing from traumatic re-experiencing. This may include mental “leaving” of the body, accompanied by decreased arousal and awareness.20 Subjectively, this can be experienced as disconnection, physical or emotional numbing, altered senses, or zoning out. Depersonalization, marked by a sense of separation from oneself, and derealization, characterized by a sense of detachment from the external world, are frequently encountered, transdiagnostic secondary dissociative symptoms, occurring in the peritraumatic context or in a range of psychiatric diagnoses, including anxiety disorders, trauma-related disorders such as PTSD and dissociative disorders.2,6,14

Chronic secondary dissociative symptoms are generally considered more severe than primary dissociation. Like more severe forms, they are linked to pervasive threats during childhood and chronic or repeated inescapable threats such as captivity or domestic violence.6 Secondary dissociation has been conceptualized as a state of helplessness, wherein

The individual has seemingly concluded that escape is extremely unlikely, and thus has made no efforts toward that end [and] the mind reflexively relinquishes executive control to a lower-order survival mechanism.

20 Secondary dissociation is a common feature of cPTSD, PTSD-DS, and BPD and frequently associated with heightened suicidality, non-suicidal self-injury, and other potentially destructive coping behaviors.1,2

The most severe forms of dissociation include Unspecified or Other Specified Dissociative Disorder (U/OSDD) or Dissociative Identity Disorder (DID), as described in trait, tertiary, structural and multiplicity dissociation models.2,20–24 This is generally believed to result from severe, recurrent early childhood harm, and reflect the impact of chronic and unrelenting fear in the absence of consistent parental care.2,8 Personality development is disrupted, evolving into multiple ego or self-states with distinct cognitive, affective, and behavioral patterns, often accompanied by partial or full amnesia in between states.25 This category is associated with profound changes in nervous system development and function, serious functional impairment due to amnesia and altered consciousness, emotion dysregulation, and a confusing array of symptoms disconnected from awareness of trauma cues.12,22,23 It also carries a high risk of suicidality, self-harm, and psychiatric comorbidity.2,12,14

While trauma-related dissociation is a complex topic, basic dissociative processes are firmly rooted in our biology. In the next sections, dissociation will be discussed from an evolutionary lens, highlighting its role in our threat response system, intersections with attachment and neurobiology, and implications for clinical care.

An Evolutionary Perspective on Trauma-Related Dissociation

Understanding the close connection between dissociation and threat responses requires an evolutionary perspective dating back to the emergence of predator–prey relationships around 500 million years ago.26–28 In the beginning, primitive life forms had two survival mechanisms—movement and immobility—for pursuing and consuming other creatures for sustenance, fleeing from or confronting predators, or freezing in place when escape was impossible (ie, fight, flight or freeze).6,26 From these origins, every organism with a central nervous system retained and elaborated upon these highly conserved, instinctual defensive responses to prolong existence and ensure the continuation of their species. Mediated by limbic, brainstem and physiological stress response structures, such as the amygdala, hypothalamic-pituitary-adrenal axis, and autonomic nervous system, they involve fixed action patterns and release of neurotransmitters, hormones, and pain and inflammatory mediators.6,29

Freeze responses, a form of dissociation, occur when stillness, disconnection, or energy conservation is perceived as the most effective survival strategy, varying from tonic immobility to vasovagal collapse. Tonic immobility involves both sympathetic and parasympathetic arousal, immobility and opioid-mediated analgesia while maintaining muscle tone.6,29 With greater threat, there is progressive loss of sympathetic tone, and the dorsal vagus predominates, with decreased heart rate, respiration, and muscle tone, altered consciousness, and additional release of opioids.6,29 In the animal world, this is analogous to the opossum “playing dead” in response to imminent threat. These “shutdown” states are theorized to conserve energy, induce anesthesia, and potentially diminish predatory instincts elicited by movement, increasing likelihood of survival if a predator is distracted or loses interest. Thus, it is the defense of last resort during inescapable threat, employed when other options appear futile.29

Humans possess a complex nervous system that models, predicts, avoids, and responds to potential threat, building upon these active (eg, fight or flight) and inactive (eg, immobility or “freeze”) animal defensive responses.29 Depersonalization and derealization, for example, are considered to be inactive defenses akin to such freeze responses; associated altered states of consciousness are thought to be a product of altered brain function and the impact of associated opioid release.6 The type and intensity of response exist on a continuum, depending on the degree, imminence, and controllability or escapability of the threat, often related to physical capacities and proximity to safety. These involve multiple brain circuits, coordinated by the brainstem periaqueductal gray, and modified by the prefrontal and other cortical inputs.29 Imagination, mental simulation, predictive coding, and associated problem solving rely on complex cortical brain systems that integrate past and present sensory information. Extreme threat induces an intense response that inhibits the cortex and elicits fixed, primal emotional and behavioral responses (see Mobbs et al for a review).29

Humans also elaborated upon animal social defenses, including attachment and social learning, enabling care and protection of offspring and transmission of advantageous adaptations.30 Social defenses involved multiple modifications to the nervous system, including prefrontal, limbic and brainstem areas involved in mammalian sexuality and behavioral flexibility, and development of the ventral branch of the vagus nerve, allowing prolonged close proximity needed for social engagement, play, and nurturing young.19,31–33 This includes the attachment cry, which elicits a vigorous visceral urge to take immediate action, ensuring proximity for physical protection and assistance in ameliorating unmet needs, important for human infants given their prolonged dependence and defenselessness.19,29,31,34,35 This response persists throughout life, induced by separation or loss, prompting caretaking and other relational responses.30,34,35 Additionally, adaptations to oxytocin and vasopressin systems also motivate affiliative-nurturing behavior and aggressive-defensive behavior to maintain attachment bonds; these connect social information to pain, reward, anxiety and homeostatic mechanisms, including opioids, dopamine, serotonin, and stress responses.19,36

In humans, social evolution, in the form of group protection and co-regulation, became our primary strategy for both survival and well-being, likely due to our particular physical vulnerabilities to predators and environmental dangers in early hunter-scavenger-gatherer environments.29,37 This evolutionary pressure to intensify social bonding capacities needed for long-term social protection likely promoted behaviors and adaptations to understand others, manage within-group aggression and keep individuals in the good graces of other group members.29,37–39 Strong connections, both within and beyond close attachment relationships, facilitated the social and cultural transmission of these and other adaptive behaviors.30 Moreover, because humans can vividly remember danger and mentally time travel, evoking strong stress responses, seeking reassurance from others likely buffered such stresses.7,19,29 Therefore, human neurobiological systems are oriented towards seeking others not only for life-threatening situations but also for regulation of distress.

Securefulness likely evolved as a consequence of this social evolution.40 Arising from neurobiological processes responsible for awareness, self-regulation, and co-regulation, securefulness refers to prolonged states of attuned mindfulness within attachment relationships.40 This allows caregivers to anticipate and sensitively respond to infants and children, not only ensuring survival but also facilitating the child’s capacity to regulate distress, experience a sense of safety and care, and understand self and others, important for cooperative relationships.7–9,19,40,41 Secureful attachment includes bodily experiences of play, movement (eg, rocking), soft vocalizations and eye gaze, and safe, appropriate touch; this sensory input facilitates development of subcortical pathways necessary for integration of sensory and emotional information.7,18,19,42 Affective touch is also calming and elicits oxytocin, enhancing bonding, relieving pain, and influencing development of associated neurohormonal systems, with potentially epigenetic and intergenerational consequences.7,19,43–45 In summary, early securefulness experiences are the building blocks of a capable, valued, and connected sense of self within the world.8,9,18,19 In many ways, securefulness is the opposite of dissociation,40,46 a concept further explored below.

Dissociation as a Response to Primal Isolation Anguish

Just as attachment and belonging are vital to human well-being, social detachment and isolation are profoundly threatening. In this paper, we use the term primal isolation anguish to describe the neurobiological state of aloneness and terror that might accompany an infant without attachment, defenseless against predation or starvation. This state of separation involves the same neural wiring as pain, “akin to opioid withdrawal”;45 social contact eases this pain through endorphin or oxytocin release, depending on context.7,45,47 This applies to adults as much as infants, especially in hunter-scavenger-gatherer societies, where disconnect from the tribe meant almost certain death. Intense states of primal anguish, therefore, often evoke a sense of helplessness, hopelessness, or loss of control in humans, activated not only by intense threat or social isolation but also intense physical or relational pain or entrapment.7,9,45,47 We propose that this neurobiological state registers biologically as a life threat and is deeply connected with the phenomenon of dissociation.

In the evolutionary context, dissociation offers the ultimate escape for an infant or child in primal anguish. Ill-equipped to face a life threatening situation alone, a serious threat prompts a robust, all-encompassing attachment cry.31,34,35 If help is not forthcoming, dissociation is the only remaining survival response; it detaches the child from helpless terror6,8,9,19,29 Empirical research supports this, suggesting dissociation is employed as a coping mechanism when infants are left alone or are exposed to harm.8,9 Studies also confirm a strong association between early life abuse, neglect, and trauma, as well as more subtle attachment disruptions like emotional unavailability or repetitive contradictory, inconsistent or role reversal behaviors in parenting, thus implicating repeated neurobiological states of primal anguish in the development of dissociative symptoms.8,9,19

Even when dissociation becomes a repetitive response to disrupted attachment, the drive for attachment remains. Intense threat elicits a painful and inflammatory stress response that activates attachment needs, prompting relationship seeking behaviors for regulation.19,29,31,34,35 Securely attached individuals can seek support, or use internal resources to cope. However, if attachment is disrupted or pain is overwhelming, especially in situations of isolation, dissociation can occur. Severe childhood neglect or abuse forces the developing brain to mature under neurohormonal conditions of chronic terror and insecurity, with profound and often long-term impacts on brain function,10,18 including right-brain cognition related to processing faces and social cues.48 Maintaining connection with the source of physical danger also necessitates suppression of natural, active defense responses, and awareness of certain experiences.8,9,19,49 This can create cycles where attempts to communicate distress are not met and there is no regulatory outlet, prompting dissociation.8,9 A child who is a victim of sexual abuse by their parent, for instance, may alternate between dissociation induced by terror and moments of connection that ensure continuous provision of care, nourishment, and shelter. After repeated failed attempts at connection or repeated abuse, an individual may learn to avoid others altogether or incorporate the experiences as evidence of not being worthy of care, creating trauma-related states of shame.49 Such shame is itself associated with inflammation, helplessness, withdrawal, depressive and dissociative symptoms, and altered information processing.49–54 Thus, dissociation can become the default, or there may be oscillation between states of feeling out of control and states of feeling disconnected, robotic or unalive.

Neurobiology of Dissociation

Brain changes during dissociation reflect its function to reduce awareness and protect against the psychological and neurophysiological overwhelm and anguish that accompanies intense threat. Trauma-related dissociation occurs when this response persists long after the original threat is over, when reminders reactivate pathogenic memories storing intense trauma-related content. Sensory and emotional processing, the capacity to register, organize, and modulate incoming sensory and affective information, integration capacities, and brainstem areas modulating arousal and movement are key.1,6,10,18 Studies demonstrate altered activity or structure of multiple areas involved in perceiving and processing internal and external sensations (ie, sensorimotor information), pain, and emotions, memory, and awareness, such as the hippocampus, amygdala, thalamus, insula, anterior cingulate cortex, prefrontal cortex (PFC), basal ganglia and posterior association areas.1,6,18 The PFC and cingulate cortex become hyperactivated, preserving cognitive functions and overregulating the amygdala, insula, and periaqueductal gray (PAG), components of the salience network regulating attention, importance assigned to stimuli, and functioning of other networks.1,6,18,55 The brainstem coordinates release of opioids, anesthetizing pain and altering consciousness, and inhibits motor responses.6,29 Therefore, while the body continues to experience the physiological impact of stress and anguish, the mind’s awareness is blunted. While this may preserve global brain functioning, the emotional and sensory “shutdown” suppresses perception of and appropriate responses to safety and danger. Patients may appear passive or inattentive, or report symptoms of numbing, hypoarousal, or paralysis.2,6

Although initially adaptive, these states or traits have long-term functional consequences, as whole-brain integration of multisensory data is needed for higher-order brain functions, including social capacities.7,18 Widespread brain functional hyperconnectivity has been reported in those with chronic dissociative symptoms, as well as altered connectivity in the Default Mode Network (DMN), frontoparietal control networks, networks related to sensorimotor processing, and areas involved in arousal, consciousness, attention, awareness, proprioception and movement.1,18,56 Epigenetic mechanisms may also be impacted, including altered oxytocin and attachment reward responses.1,7,19 Given the involvement of the DMN, involved in self-referential processing, it is not surprising that sufferers frequently report altered sense of self and relationship to others and the world.7,10,19,55 Repeated states of clouded consciousness and variable degrees of sensory and affective information loss can lead to challenges related to memory, learning, and discontinuous personal narratives, contributing to a fragmented sense of self.19 The following section describes how these early adaptations can become maladaptive patterns in the context of psychotherapy, impairing therapeutic processes.

Dissociation in the Context of Psychotherapy

Engaging in psychotherapy requires the capacity to tolerate sensory and emotional experiences within a safe enough relationship. Individuals with chronic dissociation often struggle to feel safe, especially in relationships, making psychotherapy challenging or even terrifying. Positive and attuned interactions with therapists may evoke feelings of fear, shame, primal anguish or grief, as individuals become aware of painful past experiences. Factors like insecure attachment, shame, amnesia for events, and fear of authenticity and vulnerability can hinder engagement in psychotherapy.49,52,57 Relatively mild relational misattunements, symbolic reminders of abandonment, or states of entrapment or distress activated by internal conflict can serve as trauma cues, evoking viscerally intense threat responses. These issues may manifest in various ways, including missed appointments, distress, excessive compliance, passivity, and unexpected reactions in the therapeutic relationship.57 Additionally, it may be difficult to recognize needs, goals, values, or even the extent of their own fear. Further, dissociation-related memory impairment and sense of incapacity can make tasks like homework challenging.

The fawning response may also impact psychotherapeutic processes and impair recognition of dissociation. When humans dissociate, they often appear alive rather than dead, as attachment needs are activated by perceived threat, stirring security seeking from others.8,9,19,29 This is often expressed as a fawning response designed to maintain connection, accepting whatever is available within the relationship. In this state, patients may appear “normal”, calm, agreeable, and quiet. By mimicking attachment, they may submit to actions they believe will lead to care or connection. This complicates authentic interaction and ability to recognize wants, feelings, and thoughts – essential for establishing clear boundaries. Fawning may therefore enable people to remain attached to unhealthy or abusive relationships, saving them from the terror of aloneness or primal anguish. This can go unnoticed and people-pleasing behavior, unconsciously performed to avoid relational distress, may be misconstrued as authentic, slowing therapeutic progress.

Further, therapy can break down when stress triggers intense fight or flight responses, threatening the therapeutic relationship. When overwhelmed, human capacities such as empathy, attunement, intuition, and self and other regulation can falter, and we may revert to animal defenses, sabotaging the essential need for safe human connection.19 In these moments, relying on social connections for co-regulation, including within therapy, becomes even more crucial. However, persistent trauma-induced nervous system dysregulation perpetuates a sense of enduring threat,5 impeding access to calmer states needed for attunement and development of healthy relationships fundamental for healing.33

Trauma-focused psychotherapies may be particularly challenging for dissociative individuals, as they often require direct attention to the dissociated threatening experiences. Due to experiencing recurrent, frightening states of overwhelm, emotion itself may become a trauma cue, resulting in exquisite avoidance of emotion.58 Dissociation can block access to and therefore processing of the affectively charged trauma memory network emphasized in trauma therapies.59 Since we learn to self-regulate within relationships with attuned caregivers, childhood trauma survivors face a dual challenge: inability to access necessary content and difficulty utilizing self or co-regulation to facilitate trauma processing.7,10,18,19 Further, dissociation-related amnesia and attentional changes make it harder to acquire skills that would reduce reliance on dissociation.11,13

Given the clear importance of dissociation for clinical care, an understanding of available interventions is crucial for improving outcomes. This review examines both psychological and biological interventions for dissociative symptoms such as derealization and depersonalization; further, results will be discussed in light of the previously presented evolutionary perspective, including the view that interventions may act by enhancing an inner sense of safety.

Methods

While this is a narrative review, we used a systematic search for literature on treatment strategies for dissociative episodes. We followed the Preferred Reporting Items for Systematic reviews and Meta-Analysis (PRISMA) guidelines for scoping reviews process to enhance rigor, embedding results within a conceptual, narrative frame informed by clinical experience.60 MEDLINE (Ovid Interface 1946–2023), EMBASE (Ovid Interface 1974–2023), APA PsycINFO (Ovid Interface 1806–2023), CINAHL plus with Full Text (EBSCOhost Interface 1937–2023), and Scopus (1970–2023) databases were searched on April 13, 2023, for published peer-reviewed studies. The search strategy combined subject headings and keywords for three main concepts: dissociation or dissociative episodes, treatments, and mental disorders frequently comorbid with dissociation (see Supplementary Materials). Peer-reviewed clinical studies were included if they assessed the effect of a treatment on dissociative episodes in adults and were written in English or French. A dissociative episode was defined as the presence of functional, stress or trauma-related dissociation (eg, depersonalization, derealization) that was not induced by a drug, medical condition, or intervention (eg, hypnosis). We explicitly excluded tertiary dissociation, such as DID, as this represents an exceptionally complex disorder for which treatment is highly individualized, often long term, and typically carried out by those with special training and experience. Therefore, most studies are not designed for this population. Further, it would be challenging to integrate studies on tertiary dissociation and still present a coherent synthesis of these complexities within the space available.

The research team met regularly to ensure quality data screening, selection, extraction, and synthesis procedures. Covidence software (https://www.covidence.org) was used to remove duplicates and facilitate article screening and full-text review. The team created a data extraction form using Google Forms, which included: population characteristics (age, sex and gender, ethnicity, country, trauma type, dissociation characteristics), study design, intervention, dissociation measurement instruments, sample size, main results, dropout rate, and study limitations. Each article was reviewed independently; however, the extracted information was verified by a senior author and collated. A thematic qualitative analysis followed.61 During this process, key references known to authors with subject matter expertise were considered, with iterative literature searches as needed during manuscript development.

Results

Study and Sample Characteristics

Our search yielded 4873 articles; after duplicate removal, 2838 articles were screened, and 69 met eligibility criteria for inclusion (Tables 1–3, Figure 1). These studies included a total of 3710 participants, mostly females; no studies reported on gender identity. Most studies were conducted in either Europe (n = 37; 53.6%) or the United States (n = 28; 40.6%), and in the civilian (n = 66; 95.0%) population. Most studies were randomized controlled trials (RCT; n = 33; 47.8%) or a pre/post study design (n = 25; 36.2%), typically with 60 or fewer participants (n = 51; 73.9%). All were published between 1990 and 2023, approximately half since 2014. The impact of treatment on dissociative symptoms was the primary aim of only 15 (21.7%) studies, mostly within the context of Depersonalization Disorder (DPD). Most studies focused on either PTSD, trauma-exposed populations (n = 38; 55.1%) or BPD (n = 10; 14.5%), with dissociative symptoms as a secondary outcome. DPD studies more often focused on medications or repetitive Transcranial Magnetic Stimulation (rTMS), in contrast to PTSD and BPD studies, which included both psychotherapy and medications. Dissociation was usually measured using validated, dissociation-specific rating scales (n = 52; 75.4%), most often the Dissociative Experiences Scale (DES; n = 37; 53.6%) or Cambridge Depersonalization Scale (CDS; n = 11; 15.9%) (Table 4).

Table 1 Psychotherapy Intervention Studies and Impact on Dissociation

Table 2 Medication Intervention Studies and Impact on Dissociation

Table 3 rTMS Intervention Studies and Impact on Dissociation

Table 4 Dissociation Measures Used in the Included Studies

Figure 1 Flow diagram.

Study Interventions

Study interventions included psychotherapy (n = 50; 72.5%), medication (n = 16; 23.1%), and rTMS (n = 3; 4.3%) approaches (Tables 1–3). Psychotherapy interventions were nearly evenly divided between those employing trauma-specific therapies and non-trauma focused approaches, which will be expanded upon below.

Psychotherapeutic Interventions

Mindfulness and Body Awareness-Based Psychotherapies

Mindfulness and body-based therapy studies (n = 8) reported overall positive but mixed results, with heterogeneous designs. Six were RCTs, but some enrolled participants with modest baseline dissociative symptom scores, and only two were specifically designed to assess dissociative conditions (eg, DPD).62,68 The remaining six studies measured dissociation as an associated feature of trauma exposure or psychopathology (Table 1).

Interventions included transcendental meditation63 and body-based interventions that encouraged bodily awareness via directed attention to bodily sensations, such as Mindful Awareness in Body-oriented Therapy (MABT),64–66 Body Awareness and Dance Exercise (BA/DE),62 modified yoga,67,69 or biofeedback.68 All studies except electrodermal biofeedback reported promising results.68 This study involved altering skin conductance to manipulate an arcade game interface, facilitating awareness and control of this physiologic measure previously found to be low in DPD.68 Study participants had higher baseline dissociative symptom scores compared to many of the other studies, a possible confounder. MABT involved massage, body awareness exercises and inner body focus, whereas BA/DE involved the addition of guided body awareness to a dance exercise. Interestingly, while the BA/DE study was positive, authors noted that the most significant reduction in dissociation scores occurred immediately after dance exercise, regardless of whether directed bodily awareness was added,62 an unexpected finding.

Cognitive Behavioral, Skills-Based, and Psychoeducation Interventions

Interventions based upon Cognitive Behavioral Therapy (CBT) or Dialectical Behavior Therapy (DBT) were also common; five of seven reported improvements in dissociation. These included group and individual formats, single and multiple session interventions, and in-person and asynchronous online interventions tested for PTSD, social- or test-related anxiety, and DPD.72,73,75,76 DBT and Systems Training for Emotional Predictability and Problem Solving (STEPPS) both equally improved dissociative symptoms in BPD,71 but Mindfulness-based CBT (MCBT) did not,74 despite very similar, moderately severe baseline DES scores (26.02[SD = 14.13] vs 25.0[SD = 20.2]). Dissociation was a secondary objective in all but two studies: one focused on DPD,72 and the other on depersonalization induced by test anxiety in university students.76

Other skills-based interventions, incorporating psychoeducation and cognitive approaches, with or without coping skills, were described in an additional eight studies, improving dissociation in six (Table 1). These treatments were usually delivered in a group format (n = 6) and often included psychoeducation pertaining to symptoms of trauma and/or PTSD and an interactive component between group members. Populations studied included those with PTSD or trauma exposure, including interpersonal,77,78,80,82–84 or military trauma.81 Comorbidity with Substance Use Disorder (SUD) or pathological gambling was present in two studies.79,80 None of these studies were primarily designed to address dissociation, and one study specifically excluded those with more severe dissociative symptoms.83

Trauma-Focused Psychotherapies

Many interventions included either a specific trauma-focused therapy (n = 7), such as Eye Movement Desensitization and Reprocessing (EMDR), or a trauma-focused therapy in combination with another intervention (n = 14), including within an intensive trauma program (n = 4). Studies with a single, specific trauma-focused therapy included EMDR (n = 4),86–88,91 Narrative Exposure Therapy (NET) (n = 2),89,90 Prolonged Exposure (PE) (n = 1),91 and Hypnotherapeutic Olfactory Conditioning (HOC) (n = 1);85 all but a group-based bilateral stimulation intervention reported dissociation improvement. This study enrolled participants with severe dissociative symptoms from a specialty trauma and dissociation clinic.88 Other populations studied included PTSD or trauma exposure (n = 5),85–87,89,91 including those with comorbid BPD90 and severe mental illness with repeated interpersonal trauma.89

Treatments that combined a trauma-focused modality with another therapy were also common (n = 14 studies); all but two reported improvements in dissociation. These studies used either EMDR, an exposure-based therapy, or trauma imagery rescripting therapy combined with another intervention such as CBT or DBT-based skills training, cognitive restructuring, movement (yoga, physical activity, or equine therapy), expressive art, music, writing, supportive therapy, or psychoeducation. These studies appeared to include more complex populations such as PTSD with a history of childhood sexual or physical abuse, BPD, other trauma-related personality changes,92,96,97,100 or another Diagnostic and Statistical Manual of Mental Disorders (DSM) diagnosis.97 Treatment was often administered within trauma-specific specialty programs,93,96,97,100–104 and four studies reported on intensive, daily therapy programming.101–104

Other Psychotherapeutic Interventions

Six studies described other intervention types, including psychodynamic, Internal Family Systems (IFS), Cognitive Analytic Therapy (CAT), or interoceptive exposure. These were small, overall positive studies.105–110 All utilized dissociation-specific scales, and three focused on dissociation as the main treatment target in either DD, BPD, or PTSD.105,109,110

Pharmacological Interventions

Pharmacotherapy was the focus of 16 studies, and all but three reported positive effects on dissociative symptoms (Table 2 and Table 5). Studies reported positive results for nefazodone, clonidine, the selective serotonin reuptake inhibitors (SSRIs) paroxetine and fluvoxamine, and atypical antipsychotics asenapine, olanzapine and aripiprazole; there were mixed findings for fluoxetine, lamotrigine and opioid receptor antagonists naloxone and naltrexone (Table 5). Propranolol, when used prior to exposure therapy to augment response, was also reported as beneficial, especially in those with greater dissociative symptoms.120 Studies typically lasted up to 12 weeks, focusing on diagnoses that included BPD, PTSD, or DPD. On occasion, baseline dissociation symptoms were low and could be considered normative.115

Table 5 Pharmacological Interventions Associated with Dissociative Symptom Improvement

Four studies included opioid antagonists, with mixed results. Of the two naloxone studies, the larger, single blinded crossover study in DPD (n = 50 participants) demonstrated improvement,117 while a smaller one with nine BPD participants did not.119 Naloxone was delivered intravenously, as either a single dose ranging from 0.4 mg to 1.6 mg or in multiple increasing doses, from 2 to 10 mg, every 2–3 weeks.117,119 Two negative randomized naltrexone studies were reported together, which included participants with BPD; another DPD case series (n = 14) reported positive results.121,125 Naltrexone doses ranged from 50 to 250 mg/day, over 3–10 weeks.

Atypical antipsychotics and the anticonvulsant lamotrigine, both with mood stabilizing properties, were studied for dissociative symptoms, for up to 12 weeks. Atypical antipsychotics included aripiprazole, asenapine, and olanzapine. Studies were small and heterogenous, mainly including participants with BPD.111,112,126 One RCT (n = 51) compared asenapine to olanzapine 5–10 mg/day for 12 weeks in BPD, demonstrating improvement in BPD-related dissociation symptoms with both medications. The two small lamotrigine studies focused on DPD with mixed results; the positive case series used up to 600 mg per day over 6–21 months.122,123

Finally, antiadrenergic medications propranolol, used as an adjunct to NET, and clonidine were the focus of two RCTs, both reporting positive results. Phillipsen et al (2004) studied clonidine for BPD patients with self-harm, enrolled within a DBT program,118 and Roullet (2022) studied the impact of adding propranolol prior to NET treatment for chronic and severe PTSD.120

Neuromodulation Using rTMS

All neuromodulation studies (n = 3) examined the use of low-frequency rTMS (1 Hz) among participants with DPD.127–129 The protocol varied across studies, ranging from a single rTMS session,127 a variable protocol with up to 20 sessions over 10 weeks,128 to an intensive regimen with three sessions per day for three weeks.129 RTMS was applied to the right ventrolateral prefrontal cortex (VLPFC) or temporoparietal junction (TPJ)127–129 In all studies, rTMS was noted to reduce DPD symptoms by the end of the treatment, specifically depersonalization measured with the DES and CDS (Table 3).

Discussion

Summary

This paper summarized the empirical literature studying interventions for dissociative symptoms. This included 69 studies, overall reporting dissociative symptom reduction across a wide range of interventions, including psychotherapies, medications, and rTMS. Our results extend previous reviews reporting that both trauma-focused and non-trauma-focused treatments can reduce dissociative symptoms,130 often with greater benefit for those with more severe symptomatology.59

While results are generally positive, multiple methodological issues impact interpretation of the findings. These include small sample sizes, heterogeneity, few RCTs and use of non-specific dissociation scales, or ones with limited breadth.5,103,130,131 Many studies were not designed to assess dissociation but rather measured dissociation as a secondary outcome. Further, few studies differentiated between high and low dissociation subgroups, likely representing different psychopathology. Some reported statistically significant results that may not be clinically relevant, included participants with low baseline symptoms, or did not report on baseline scores.65,66,115 Also, whether dissociation moderates treatment response remains difficult to ascertain from these results and may depend on contextual factors, associated psychopathology, and trial methodology.5,12,59

There is a clear need, in particular, to better understand the role of pharmacotherapies for dissociative symptoms. This review found studies reporting improvements in dissociative symptoms for the following medications: nefazodone, SSRIs (paroxetine and fluvoxamine), atypical antipsychotics (asenapine, olanzapine, and aripiprazole), the alpha2 agonist clonidine, and the beta blocker propranolol, when used to augment NET. Mixed findings were reported for naloxone, naltrexone, fluoxetine, and lamotrigine. There were few studies overall, with modest rigor, which has been noted in previous reviews.132,133 Sutar and Sahu (2019) reported only paroxetine and naloxone were supported by RCTs, with modest support.132 A systematic review of opioid antagonists found only five small studies using naloxone or naltrexone for dissociative symptoms in BPD, PTSD, DD, or opioid use disorder.133 Taken together, further high-quality studies are needed.

Pharmacological mechanisms and their relationship to dissociative processes remain to be fully elucidated. Clonidine and propranolol are commonly used adjunctively for PTSD due to their antiadrenergic effects.5 Opioid antagonists may block opioid-mediated dissociative numbing and analgesia, mediated through the μ-opioid receptor, and κ-opioid receptor mediated dysphoria and alterations in consciousness.5,6,133 SSRIs and antipsychotics, on the other hand, reduce agitation, anxiety and depressive symptoms.5 In addition to D2 and 5-HT2 receptor antagonism, atypical antipsychotics have variable effects on adrenergic and other serotonin receptors.134 SSRIs enhance both top-down control of negative emotion and modulate subcortical amygdala activity.135 Over time, SSRIs can desensitize 5-HT1A autoreceptors in the dorsal raphe nucleus (DRN).136 Serotonin release from the DRN to the PAG is implicated in passive defensive responding to inescapable threats and perception of powerlessness, with potential implications for dissociation;137 a range of other neurotransmitters, including dopamine, opioids, cannabinoids, and oxytocin, are also implicated in associated PAG mediated threat responses.138,139 Interestingly, ameliorating learned helplessness, a response to inescapable or uncontrollable threat, has also been explored as a common therapeutic mechanism for psychedelics and ketamine.140 MDMA-assisted therapy, which facilitates a sense of safety and trust through oxytocin release, may be of particular interest to the field of dissociation.141

RTMS, which uses magnetic fields to excite or inhibit neurons in specific regions of the brain, is a novel option for DPD.142 rTMS has been studied for other related psychiatric disorders, including depression and PTSD, usually with high frequency (ie, stimulatory) rTMS applied to the right or left DLPFC.5,142 However, studies using rTMS for DPD targeted the right VLPFC or TPJ with low frequency (ie, inhibitory) protocols.127–129 The TPJ is an integration area associated with social cognition, attention and self-awareness and implicated in neglect and depersonalization;6,143,144 both the DLPFC and VLPFC are involved in emotion regulation, including in response to social pain.144–146 This fits with the fronto-limbic inhibition model of dissociation, with PTSD-DS exhibiting PFC overregulation of amygdala activation, relative to classic PTSD.6 Notably, rTMS effects are specific to the brain area targeted, theoretically allowing customization; in theory, further elucidation of neurobiology specific to dissociation subtypes may lead to greater rTMS protocol specificity.

Safety as Foundational for Dissociation Treatment

It is useful to consider that most, if not all, helpful interventions directly or indirectly modulate threat response systems, thereby promoting a sense of inner safety. For example, cognitive and emotional regulation interventions directly enhance a sense of safety by reducing physiological distress and improving self-efficacy, whereas trauma-focused interventions desensitize pathogenic memories perpetuating chronic threat responses. Medications and rTMS also impact neurobiological systems relevant to internal distress, such as autonomic reactivity, executive and emotional regulatory capacity, or dissociative processes.5,6,127,129,133,134,142

Dissociation stands in stark contrast to safety. This review frames dissociation as a defense response to primal isolation anguish, a state of terrifying helplessness and aloneness. Severe chronic dissociative symptoms are understood as a consequence of brain adaptations to environments devoid of reliable relational safety and often repeated or prolonged experiences of inescapable terror and abandonment.7,8,18,19 Such circumstances not only result in insecure attachment but also profoundly impact the way the brain develops, adapting by shutting down somatosensory integration between cortical and subcortical areas.18 While this allows survival, it inhibits development of a robust experiential template for safety, prevents the person from being able to tolerate and use interoceptive and exteroceptive information to accurately assess and respond to present danger, and robs the person of the capacity to feel a coherent sense of being an agentive self.18,19 In summary, in general, attachment injury prevents those impacted from feeling safe and from being mindful of difficult bodily experiences on their own.

This has direct implications for mindfulness and psychotherapy in general. Mindfulness involves present moment awareness, with acceptance, including of somatosensory experience. However, many of those with dissociative symptoms missed the repeated, attuned attachment experiences necessary to internalize a sense of safety and comfortably be alone with internal experience.40,46 When present, dissociated trauma-related content can flood awareness, prompting further dissociation.40,58,147,148 Rather than expecting solo practice, in-session or within-group practices with mindful, relational co-regulation (ie, securefulness) may be needed to prevent overwhelm.40 This principle also applies to helping patients tolerate painful content in treatment generally, regardless of modality.

The concept of securefulness adds to mainstream conceptualizations of therapeutic alliance, which is a consistent driver of therapeutic outcomes.149 As it implies a neurophysiological state, securefulness may lend to physiological studies of therapist-patient dyads and more objective adjunctive measures of alliance and psychological safety. Such measures may be especially helpful for dissociative individuals, where fawning and reduced internal awareness can complicate assessment. Physiological measures, perhaps captured through wearable devices, may also help therapists identify triggers for dissociation, pace therapy and balance the need to support and the need to teach patients how to nurture themselves. As dissociation can disrupt emotional learning and slow progress, perhaps such tools could be used to recognize and mitigate such effects.11

Top-Down and Bottom-Up

Kearney and Lanius (2022) proposed that optimal treatment for traumatized patients combines “top-down” (eg, cognitive) with “bottom-up” (eg, body based) strategies, allowing for vertical integration of brain processing. They conceptualize trauma-related symptoms as foundationally

Grounded in brainstem-level somatic sensory processing dysfunction and its cascading influences on physiological arousal modulation, affect regulation, and higher-order capacities.

18 Such integrative treatment would facilitate the connections between brainstem, vestibular and cerebellar connections with the body, the reticular activating system that governs level of consciousness, limbic areas for memory, emotion and secure attachment, with sensory relay and integration areas (eg, thalamus, insula), and higher cortical functions. For example, therapies that include somatosensory and vestibular stimulation, such as play therapy, might facilitate such a process, especially if integrating safe relational experience. Such experiences not only build sensory distress tolerance, mindfulness, and attentional control but also help to build a sense of safety, connection, and agency in one’s body and within the therapeutic relationship and differentiate safe from unsafe sensation.

Several current and novel interventions can be considered integrative, employing both top-down and bottom-up strategies. Examples from this review include EMDR,86 dance,62 MABT,66 modified yoga,67,69 biofeedback,68 and interoceptive exposure.109 Intensive trauma programs often added physical activities to trauma focused modalities.103 Other examples include somatic trauma psychotherapies (eg, Somatic Experiencing and Sensorimotor Psychotherapy), Deep Brain Reorienting, and Multi-Modal Motion-Assisted Memory Desensitization and Reconsolidation (3MDR).5,18,150 EMDR combines top-down activation of the PFC and attentional control with direct effects on the brainstem to engage sensory integration.18 Somatic psychotherapies similarly engage attentional control, emotion regulation, and mindful experiencing of somatosensory states. Deep Brain Reorienting focuses on subcortical orienting, shock, and PAG-based affective responses associated with traumatic memories, without discussing traumatic content.150 Finally, 3MDR includes treadmill walking, somatosensory processing, and an eye movement task within a virtual reality exposure environment.5 All emphasize co-regulation and safety of the therapeutic context, to titrate experience.

Other Opportunities for Research

This review raises research opportunities related to dissociation. Far from monolithic, dissociative symptoms may serve different functions, such as avoiding sensory experience, specific emotions, inner conflict, or vulnerability; further, there may be clinically important neurobiological subtypes. Research to improve matching of patients to therapies or therapy combinations, perhaps integrating top-down and bottom-up strategies, is indicated. Feasible clinical assessment and symptom measurement tools that assess dissociative symptoms over time would be helpful in this endeavor. Sixty percent of studies used the self-rated DES II screening measure, which has no set time frame, is vulnerable to subjective interpretation and can miss indicators of somatoform dissociation. Validated, practical tools for measuring felt sense of safety and securefulness could also facilitate research in this area, although this remains to be empirically tested.

Limitations

This review focused on empirical studies of interventions that reported an impact on trauma-related dissociation such as derealization and depersonalization, excluding severe forms of identity dissociation. Most studies did not explicitly exclude such disorders, however, which are under-recognized and could have been included in the reviewed studies.12 There are few well-designed studies to guide treatment in this complex cohort, although literature demonstrates improvement in therapy.2,12 Additionally, no qualitative studies were captured as part of our search, representing a potential research gap. This review is also limited to studies in English or French, potentially overlooking research from other regions or languages.

Conclusion

Trauma-related dissociation is a complex, transdiagnostic phenomenon involving brain and body systems designed for perceiving and responding to severe threats, including the primal isolation anguish of being alone and helpless. For humans, this is intertwined with attachment, the primary method we evolved for maintaining safety, especially during developmental years. Chronic or recurrent dissociative symptoms are associated with severe and often repeated inescapable threat, often in the form of attachment or interpersonal trauma. Therefore, we propose that relational safety and attunement, termed Securefulness, be prioritized in treatment, regardless of modality.

A range of interventions are associated with reduced dissociative symptoms, including pharmacotherapies, rTMS, and a variety of psychotherapy and behavioral approaches. However, many methodological issues and knowledge gaps remain to be addressed. When viewed through an evolutionary, relational and neurobiological perspective, these treatments promote an internal sense of safety through their action on threat and regulatory systems. Given the importance of relational safety, future studies should consider the quality of relationship within interventional trials, to further delineate this factor in trial outcomes and for clinical care. 

Acknowledgments

A special thank you to Liz Dennett, a librarian at the Geoffrey and Robyn Sperber Health Sciences Library, for reviewing our search strategy.

Disclosure

The authors report no conflicts of interest in this work.

References

1. Roydeva MI, Reinders AA. Biomarkers of pathological dissociation: a systematic review. Neurosci Biobehav Rev. 2021;123:120–202.

2. Loewenstein RJ. Dissociation debates: everything you know is wrong. Dialog Clin Neurosci. 2018;20(3):229–242. doi:10.31887/DCNS.2018.20.3/rloewenstein

3. Fung HW, Chien WT, Lam SKK, Ross CA. The relationship between dissociation and complex post-traumatic stress disorder: a scoping review. Trauma Violence Abuse. 2023;24(5):2966–2982. doi:10.1177/15248380221120835

4. Sommer JL, Blaney C, Mota N, et al. Dissociation as a transdiagnostic indicator of self‐injurious behavior and suicide attempts: a focus on posttraumatic stress disorder and borderline personality disorder. Journal of Traumatic Stress. 2021;34(6):1149–1158. doi:10.1002/jts.22726

5. Burback L, Brémault-Phillips S, Nijdam MJ, McFarlane A, Vermetten E. Treatment of posttraumatic stress disorder: a state-of-The-art review. Curr Neuropharmacol. 2023;22(4):557–635.

6. Lanius RA, Boyd JE, McKinnon MC, et al. A review of the neurobiological basis of trauma-related dissociation and its relation to cannabinoid-and opioid-mediated stress response: a transdiagnostic, translational approach. Current Psychiatry Reports. 2018;20:1–4. doi:10.1007/s11920-018-0983-y

7. Clark ELM, Jiao Y, Sandoval K, Biringen Z. Neurobiological implications of parent-child emotional availability: a review. Brain Sci. 2021;11(8):1016. doi:10.3390/brainsci11081016

8. Lyons-Ruth K. Dissociation and the parent–infant dialogue: a longitudinal perspective from attachment research. Attachment. 2015;9(3):253–276.

9. Guérin-Marion C, Sezlik S, Bureau JF. Developmental and attachment-based perspectives on dissociation: beyond the effects of maltreatment. Europ J Psychotraumatol. 2020;11(1):1802908. doi:10.1080/20008198.2020.1802908

10. Teicher MH, Gordon JB, Nemeroff CB. Recognizing the importance of childhood maltreatment as a critical factor in psychiatric diagnoses, treatment, research, prevention, and Education. Mol Psychiatry. 2021;27(3):1331–1338. doi:10.1038/s41380-021-01367-9

11. Al-Shamali HF, Winkler O, Talarico F, et al. A systematic scoping review of dissociation in borderline personality disorder and implications for research and clinical practice: exploring the fog. Aust N Z J Psychiatry. 2022;56(10):1252–1264. doi:10.1177/00048674221077029

12. Brand BL, Classen CC, McNary SW, Zaveri P. A review of dissociative disorders treatment studies. J Nerv Ment Dis. 2009;197(9):646–654. doi:10.1097/NMD.0b013e3181b3afaa

13. Brand BL, Stadnik R. What contributes to predicting change in the treatment of dissociation: initial levels of dissociation, PTSD, or overall distress? J Traum Dissoc. 2013;14(3):328–341. doi:10.1080/15299732.2012.736929

14. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th. Washington D.C; 2013.

15. Butler LD. Normative dissociation. Psychiat Clin. 2006;29(1):45–62. doi:10.1016/j.psc.2005.10.004

16. Van der Hart O, Horst R. The dissociation theory of Pierre Janet. Journal of Traumatic Stress. 1989;2(4):397–412. doi:10.1002/jts.2490020405

17. Lebois LA, Kumar P, Palermo CA, et al. Deconstructing dissociation: a triple network model of trauma-related dissociation and its subtypes. Neuropsychopharmacology. 2022;47(13):2261–2270. doi:10.1038/s41386-022-01468-1

18. Kearney BE, Lanius RA. The brain-body disconnect: a somatic sensory basis for trauma-related disorders. Front Neurosci. 2022;16:1881.

19. Lahousen T, Unterrainer HF, Kapfhammer HP. Psychobiology of attachment and trauma-some general remarks from a clinical perspective. Front Psychiatry. 2019;10:914. doi:10.3389/fpsyt.2019.00914

20. Frewen PA, Lanius RA. Neurobiology of dissociation: unity and disunity in mind–body–brain. Psychiat Clin. 2006;29(1):113–128. doi:10.1016/j.psc.2005.10.016

21. Condon LP, Lynn SJ. State and trait dissociation: evaluating convergent and discriminant validity. Imagination, Cognition and Personality. 2014;34(1):25–37. doi:10.2190/IC.34.1.c

22. Dorahy MJ, Gold SN, O’Neil JA. Dissociation and the Dissociative Disorders: Past, Present, Future. Routledge, Taylor & Francis Group; 2023.

23. Nijenhuis E, van der Hart O, Steele K. Trauma-related structural dissociation of the personality. Activit Nervos Super. 2010;52:1–23. doi:10.1007/BF03379560

24. Brand BL, Lanius R, Vermetten E, Loewenstein RJ, Spiegel D. Where are we going? An update on assessment, treatment, and neurobiological research in dissociative disorders as we move toward the DSM-5. J Traum Dissoc. 2012;13(1):9–31. doi:10.1080/15299732.2011.620687

25. Van der Kolk BA, Van der Hart O, Marmar CR. Dissociation and information processing in posttraumatic stress disorder. In: van der Kolk BA, McFarlane AC, Weisaeth L, editors. Traumatic Stress: The Effects of Overwhelming Experience on Mind, Body, and Society. New York: Guilford Press; 1996:303–327.

26. Barrett LF. The half lesson your brain is not thinking. In: Barrett LF, editor. Seven and a Half Lessons About the Brain. New York: Houghton Mifflin; 2020:1–3.

27. Zhang G, Parry LA, Vinther J, Ma X. Exceptional soft tissue preservation reveals a cnidarian affinity for a Cambrian phosphatic tubicolous enigma. Proc Biol Sci. 2022;289(1986):20221623. doi:10.1098/rspb.2022.1623

28. Bertrand S, Escriva H. Evolutionary crossroads in developmental biology: amphioxus. Development. 2011;138(22):4819–4830. doi:10.1242/dev.066720

29. Mobbs D, Hagan CC, Dalgleish T, Silston B, Prévost C. The ecology of human fear: survival optimization and the nervous system. Front Neurosci. 2015;9:55. doi:10.3389/fnins.2015.00055

30. Granqvist P. Attachment, culture, and gene-culture co-evolution: expanding the evolutionary toolbox of attachment theory. Attachment & Human Development. 2021;23(1):90–113. doi:10.1080/14616734.2019.1709086

31. MacLean PD. Brain evolution relating to family, play, and the separation call. Arch. Gen. Psychiatry. 1985;42(4):405–417. doi:10.1001/archpsyc.1985.01790270095011

32. Panksepp J, Northoff G. The trans-species core SELF: the emergence of active cultural and neuro-ecological agents through self-related processing within subcortical-cortical midline networks. Consciousn Cognit. 2009;18(1):193–215. doi:10.1016/j.concog.2008.03.002

33. Porges SW. The polyvagal theory: phylogenetic substrates of a social nervous system. Int J Psychophysiol. 2001;42(2):123–146. doi:10.1016/S0167-8760(01)00162-3

34. Newman JD. Neural circuits underlying crying and cry responding in mammals. Behav Brain Res. 2007;182(2):155–165. doi:10.1016/j.bbr.2007.02.011

35. Nelson JK. The meaning of crying based on attachment theory. Clinical Social Work Journal. 1998;26(1):9–22. doi:10.1023/A:1022841427355

36. Miller TV, Caldwell HK. Oxytocin during Development: possible Organizational Effects on Behavior. Front Endocrinol. 2015;6:76. doi:10.3389/fendo.2015.00076

37. Potts R. Early human predation. Predator. 2003;2003:359–376.

38. Landers M, Sznycer D. The evolution of shame and its display. Evol Hum Sci. 2022;4:e45.

39. Hare B. Survival of the friendliest: homo sapiens evolved via selection for prosociality. Annual Review of Psychology. 2017;68:155–186. doi:10.1146/annurev-psych-010416-044201

40. Danylchuk L, Forner C. Securefulness: a Care-Centered Approach to Therapy. In: Christensen E, editor. Perspectives of Dissociative Identity Responses: Ethical, Historical and Cultural Issues. Oklahoma: HWC Press; 2022:387–418.

41. De Wolff MS, Van Ijzendoorn MH. Sensitivity and attachment: a meta‐analysis on parental antecedents of infant attachment. Child Development. 1997;68(4):571–591.

42. Farroni T, Della Longa L, Valori I. The self-regulatory affective touch: a speculative framework for the development of executive functioning. Curr Opin Behav Sci. 2022;43:167–173. doi:10.1016/j.cobeha.2021.10.007

43. Van Puyvelde M, Gorissen AS, Pattyn N, McGlone F. Does touch matter? The impact of stroking versus non-stroking maternal touch on cardio-respiratory processes in mothers and infants. Physiol Behav. 2019;207:55–63. doi:10.1016/j.physbeh.2019.04.024

44. Brzozowska A, Longo MR, Mareschal D, Wiesemann F, Gliga T. Oxytocin but not naturally occurring variation in caregiver touch associates with infant social orienting. Development Psychobiol. 2022;64(6):e22290. doi:10.1002/dev.22290

45. Morrison I. Keep calm and cuddle on: social touch as a stress buffer. Adapt Hum Behav Physiol. 2016;2:344–362. doi:10.1007/s40750-016-0052-x

46. Forner C. What mindfulness can learn about dissociation and what dissociation can learn from mindfulness. J Traum Dissoc. 2019;20(1):1–5. doi:10.1080/15299732.2018.1502568

47. Yu H, Miao W, Ji E, et al. Social touch-like tactile stimulation activates a tachykinin 1-oxytocin pathway to promote social interactions. Neuron. 2022;110(6):1051–1067. doi:10.1016/j.neuron.2021.12.022

48. DeYoung PA. Understanding and treating chronic shame: a relational/neurobiological approach. Routledge; 2015.

49. Rudy JA, McKernan S, Kouri N, D’Andrea W. A meta‐analysis of the association between shame and dissociation. Journal of Traumatic Stress. 2022;35(5):1318–1333. doi:10.1002/jts.22854

50. DeCou CR, Lynch SM, Weber S, et al. On the association between trauma-related shame and symptoms of psychopathology: a meta-analysis. Trauma, Violence, & Abuse. 2023;24(3):1193–1201. doi:10.1177/15248380211053617

51. Gruenewald TL, Kemeny ME, Aziz N, Fahey JL. Acute threat to the social self: shame, social self-esteem, and cortisol activity. Psychosomatic Med. 2004;66(6):915–924. doi:10.1097/01.psy.0000143639.61693.ef

52. Benau K. Shame, pride and dissociation: estranged bedfellows, close cousins and some implications for psychotherapy with relational trauma part i: phenomenology and conceptualization. Mediterran J Clinl Psychol. 2020;8(1):1.

53. Terpou BA, Lloyd CS, Densmore M, et al. Moral wounds run deep: exaggerated midbrain functional network connectivity across the default mode network in posttraumatic stress disorder. J Psychiatry Neurosci. 2022;47(1):E56–E66. doi:10.1503/jpn.210117

54. Lloyd CS, Nicholson AA, Densmore M, et al. Shame on the brain: neural correlates of moral injury event recall in posttraumatic stress disorder. Depression Anxiety. 2021;38(6):596–605. doi:10.1002/da.23128

55. Lebois LA, Li M, Baker JT, et al. Large-scale functional brain network architecture changes associated with trauma-related dissociation. Am J Psychiatry. 2021;178(2):165–173. doi:10.1176/appi.ajp.2020.19060647

56. Shaw SB, Terpou BA, Densmore M, et al. Large-scale functional hyperconnectivity patterns in trauma-related dissociation: an RS-fMRI study of PTSD and its dissociative subtype. Nature Mental Health. 2023;1(10):711–721. doi:10.1038/s44220-023-00115-y

57. Courtois CA, Ford JD. Treatment of complex trauma: a sequenced, relationship-based approach. Guilford Press; 2012.

58. Nester MS, Boi C, Brand BL, Schielke HJ. The reasons dissociative disorder patients self-injure. Europ J Psychotraumatol. 2022;13(1):2026738. doi:10.1080/20008198.2022.2026738

59. Cloitre M, Petkova E, Wang J, Lu Lassell F. An examination of the influence of a sequential treatment on the course and impact of dissociation among women with PTSD related to childhood abuse. Depress Anxiety. 2012;29(8):709–717. doi:10.1002/da.21920

60. Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.

61. Levac D, Colquhoun H, O’Brien KK. Scoping studies: advancing the methodology. Implement Sci. 2010;5:69. doi:10.1186/1748-5908-5-69

62. Millman LSM, Hunter ECM, Terhune DB, Orgs G. Online structured dance/movement therapy reduces bodily detachment in depersonalization-derealization disorder. Complement Therap Clin Pract. 2023;51:101749. doi:10.1016/j.ctcp.2023.101749

63. Nidich S, O’connor T, Rutledge T, et al. Reduced trauma symptoms and perceived stress in male prison inmates through the transcendental meditation program: a randomized controlled trial. Perm J. 2016;20(4):16–17. doi:10.7812/TPP/16-007

64. Price C. Body-oriented therapy in recovery from child sexual abuse: an efficacy study. Altern Ther Health Med. 2005;11(5):46–57.

65. Price C. Body-oriented therapy in sexual abuse recovery: a pilot-test comparison. J Body Move Therap. 2006;10(1):58–64. doi:10.1016/j.jbmt.2005.03.001

66. Price CJ, Wells EA, Donovan DM, Rue T. Mindful awareness in body-oriented therapy as an adjunct to women’s substance use disorder treatment: a pilot feasibility study. J Subst Abuse Treat. 2012;43(1):94–107. doi:10.1016/j.jsat.2011.09.016

67. Price M, Spinazzola J, Musicaro R, et al. Effectiveness of an extended yoga treatment for women with chronic posttraumatic stress disorder. J Altern Complement Med. 2017;23(4):300–309. doi:10.1089/acm.2015.0266

68. Schoenberg PL, Sierra M, David AS. Psychophysiological investigations in depersonalization disorder and effects of electrodermal biofeedback. J Trauma Dissociation. 2012;13(3):311–329. doi:10.1080/15299732.2011.606742

69. Willy-Gravley S, Beauchemin J, Pirie P, Gomes A, Klein E. A randomized controlled trial of yoga with incarcerated females: impacts on emotion regulation, body dissociation, and warnings of substance relapse. Social Work Res. 2021;45(1):20–29. doi:10.1093/swr/svaa023

70. Davis JL, Rhudy JL, Pruiksma KE, et al. Physiological predictors of response to exposure, relaxation, and rescripting therapy for chronic nightmares in a randomized clinical trial. J Clin Sleep Med. 2011;7(6):622–631. doi:10.5664/jcsm.1466

71. Guillén Botella V, García-Palacios A, Bolo Miñana S, Baños R, Botella C, Marco JH. Exploring the effectiveness of dialectical behavior therapy versus systems training for emotional predictability and problem solving in a sample of patients with borderline personality disorder. J Pers Disord. 2021;35(Suppl A):21–38. doi:10.1521/pedi_2020_34_477

72. Hunter EC, Baker D, Phillips ML, Sierra M, David AS. Cognitive-behaviour therapy for depersonalisation disorder: an open study. Behav Res Ther. 2005;43(9):1121–1130. doi:10.1016/j.brat.2004.08.003

73. Klein B, Mitchell J, Abbott J, et al. A therapist-assisted cognitive behavior therapy internet intervention for posttraumatic stress disorder: pre-, post- and 3-month follow-up results from an open trial. J Anxiety Disord. 2010;24(6):635–644. doi:10.1016/j.janxdis.2010.04.005

74. Sachse S, Keville S, Feigenbaum J. A feasibility study of mindfulness-based cognitive therapy for individuals with borderline personality disorder. Psychol Psychother. 2011;84(2):184–200. doi:10.1348/147608310X516387

75. Schweden TLK, Pittig A, Bräuer D, Klumbies E, Kirschbaum C, Hoyer J. Reduction of depersonalization during social stress through cognitive therapy for social anxiety disorder: a randomized controlled trial. J Anxiety Disord. 2016;43:99–105. doi:10.1016/j.janxdis.2016.09.005

76. Schweden TLK, Konrad AC, Wekenborg MK, Hoyer J. Evaluation of a brief cognitive behavioral group intervention to reduce depersonalization in students with high levels of trait test anxiety: a randomized controlled trial. Anxiety Stress Coping. 2020;33(3):266–280. doi:10.1080/10615806.2020.1736936

77. Karatzias T, Ferguson S, Gullone A, Cosgrove K. Group psychotherapy for female adult survivors of interpersonal psychological trauma: a preliminary study in Scotland. J Ment Health. 2016;25(6):512–519. doi:10.3109/09638237.2016.1139062

78. Lubin H, Loris M, Burt J, Johnson DR. Efficacy of Psychoeducational Group Therapy in reducing symptoms of posttraumatic stress disorder among multiply traumatized women. Am J Psychiatry. 1998;155(9):1172–1177. doi:10.1176/ajp.155.9.1172

79. Najavits LM, Smylie D, Johnson K, Lung J, Gallop RJ, Classen CC. Seeking safety therapy for pathological gambling and PTSD: a pilot outcome study. J Psychoactive Drugs. 2013;45(1):10–16. doi:10.1080/02791072.2013.763557

80. Najavits LM, Johnson KM. Pilot study of Creating Change, a new past-focused model for PTSD and substance abuse. Am J Addict. 2014;23(5):415–422. doi:10.1111/j.1521-0391.2014.12127.x

81. Protopopescu A, O’Connor C, Cameron D, Boyd JE, Lanius RA, McKinnon MC. A pilot randomized controlled trial of goal management training in Canadian military members, veterans, and public safety personnel experiencing post-traumatic stress symptoms. Brain Sci. 2022;12(3):377. doi:10.3390/brainsci12030377

82. Roe-Sepowitz DE, Bedard LE, Pate KN, Hedberg EC. Esuba: a psychoeducation group for incarcerated survivors of abuse. Int J Offender Ther Comp Criminol. 2014;58(2):190–208. doi:10.1177/0306624X12465410

83. Rudstam G, Elofsson UOE, Söndergaard HP, Bonde LO, Beck BD. Trauma-focused group music and imagery with women suffering from PTSD/complex PTSD: a randomized controlled study. Europ J Trau Dissoc. 2022;6(3):100277. doi:10.1016/j.ejtd.2022.100277

84. Zlotnick C, Shea TM, Rosen K, et al. An affect-management group for women with posttraumatic stress disorder and histories of childhood sexual abuse. J Trauma Stress. 1997;10(3):425–436. doi:10.1002/jts.2490100308

85. Abramowitz EG, Lichtenberg P. A new hypnotic technique for treating combat-related posttraumatic stress disorder: a prospective open study. Int J Clin Exp Hypn. 2010;58(3):316–328. doi:10.1080/00207141003760926

86. Carletto S, Oliva F, Barnato M, et al. EMDR as add-on treatment for psychiatric and traumatic symptoms in patients with substance use disorder. Front Psychol. 2018;8:2333. doi:10.3389/fpsyg.2017.02333

87. Covers MLV, de Jongh A, Huntjens RJC, de Roos C, van den Hout M, Bicanic IAE. Early intervention with eye movement desensitization and reprocessing (EMDR) therapy to reduce the severity of post-traumatic stress symptoms in recent rape victims: a randomized controlled trial. Eur J Psychotraumatol. 2021;12(1):1943188. doi:10.1080/20008198.2021.1943188

88. Gonzalez-Vazquez AI, Rodriguez-Lago L, Seoane-Pillado MT, Fernández I, García-Guerrero F, Santed-Germán MA. The progressive approach to EMDR group therapy for complex trauma and dissociation: a case-control study. Front Psychol. 2018;8:2377. doi:10.3389/fpsyg.2017.02377

89. Mauritz M, Goossens P, Jongedijk R, Vermeulen H, van Gaal B. Investigating the efficacy and experiences with narrative exposure therapy in severe mentally ill patients with comorbid post-traumatic stress disorder receiving flexible assertive community treatment: a mixed methods study. Front Psychiatry. 2022;13:804491. doi:10.3389/fpsyt.2022.804491

90. Pabst A, Schauer M, Bernhardt K, et al. Evaluation of narrative exposure therapy (NET) for borderline personality disorder with comorbid posttraumatic stress disorder. Clin Neuropsych. 2014;11(4):108–117.

91. Rothbaum BO, Astin MC, Marsteller F. Prolonged exposure versus eye movement desensitization and reprocessing (EMDR) for PTSD rape victims. J Trauma Stress. 2005;18(6):607–616. doi:10.1002/jts.20069

92. Beck BD, Meyer SL, Simonsen E, et al. Music therapy was noninferior to verbal standard treatment of traumatized refugees in mental health care: results from a randomized clinical trial. Eur J Psychotraumatol. 2021;12(1):1930960. doi:10.1080/20008198.2021.1930960

93. Bowen A, Shelley M, Helmes E, Landman M. Disclosure of traumatic experiences, dissociation, and anxiety in group therapy for posttraumatic stress. Anxiety Stress Coping. 2010;23(4):449–461. doi:10.1080/10615800903414315

94. Classen C, Koopman C, Nevillmanning K, Spiegel D. A preliminary report comparing trauma-focused and present-focused group therapy against a wait-listed condition among childhood sexual abuse survivors with PTSD. J Aggression Maltreat Trauma. 2001;4(2):265–288. doi:10.1300/J146v04n02_12

95. Görg N, Priebe K, Deuschel T, et al. Computer-assisted in sensu exposure for posttraumatic stress disorder: development and evaluation. JMIR Ment Health. 2016;3(2):e27. doi:10.2196/mental.5697

96. Harned MS, Korslund KE, Linehan MM. A pilot randomized controlled trial of dialectical behavior therapy with and without the dialectical behavior therapy prolonged exposure protocol for suicidal and self-injuring women with borderline personality disorder and PTSD. Behav Res Ther. 2014;55:7–17. doi:10.1016/j.brat.2014.01.008

97. Kleindienst N, Steil R, Priebe K, et al. Treating adults with a dual diagnosis of borderline personality disorder and posttraumatic stress disorder related to childhood abuse: results from a randomized clinical trial. J Consult Clin Psychol. 2021;89(11):925–936. doi:10.1037/ccp0000687

98. McDonagh A, Friedman M, McHugo G, et al. Randomized trial of cognitive-behavioral therapy for chronic posttraumatic stress disorder in adult female survivors of childhood sexual abuse. J Consult Clin Psychol. 2005;73(3):515–524. doi:10.1037/0022-006X.73.3.515

99. Raabe S, Ehring T, Marquenie L, Arntz A, Kindt M. Imagery Rescripting as a stand-alone treatment for posttraumatic stress disorder related to childhood abuse: a randomized controlled trial. J Behav Ther Exp Psychiatry. 2022;77:101769. doi:10.1016/j.jbtep.2022.101769

100. Steil R, Dittmann C, Müller-Engelmann M, Dyer A, Maasch AM, Priebe K. Dialectical behaviour therapy for posttraumatic stress disorder related to childhood sexual abuse: a pilot study in an outpatient treatment setting. Eur J Psychotraumatol. 2018;9(1):1423832. doi:10.1080/20008198.2018.1423832

101. Steele E, Wood DS, Usadi E, Applegarth DM. TRR’s warrior camp: an intensive treatment program for combat trauma in active military and veterans of all eras. Mil Med. 2018;183(suppl_1):403–407. doi:10.1093/milmed/usx153

102. Steuwe C, Rullkötter N, Ertl V, et al. Effectiveness and feasibility of Narrative Exposure Therapy (NET) in patients with borderline personality disorder and posttraumatic stress disorder - A pilot study. BMC Psychiatry. 2016;16:254. doi:10.1186/s12888-016-0969-4

103. Zoet HA, Wagenmans A, van Minnen A, de Jongh A. Presence of the dissociative subtype of PTSD does not moderate the outcome of intensive trauma-focused treatment for PTSD. Eur J Psychotraumatol. 2018;9(1):1468707. doi:10.1080/20008198.2018.1468707

104. Zoet HA, de Jongh A, van Minnen A. Somatoform dissociative symptoms have no impact on the outcome of trauma-focused treatment for severe PTSD. J Clin Med. 2021;10(8):1553. doi:10.3390/jcm10081553

105. Damsa C, Lazignac C, Miller N, Maris S, Adam E, Rossignon K. Lipid levels in dissociative disorders: effects of psychodynamic psychotherapy. Psychiatr Q. 2014;85(3):369–376. doi:10.1007/s11126-014-9297-3

106. Gregory RJ, Chlebowski S, Kang D, et al. A controlled trial of psychodynamic psychotherapy for co-occurring borderline personality disorder and alcohol use disorder. Psychotherapy. 2008;45(1):28–41. doi:10.1037/0033-3204.45.1.28

107. Hodgdon HB, Anderson FG, Southwell E, Hrubec W, Schwartz R. Internal Family Systems (IFS) therapy for posttraumatic stress disorder (PTSD) among survivors of multiple childhood trauma: a pilot effectiveness study. J Aggression Maltreat Trauma. 2021;31(1):22–43. doi:10.1080/10926771.2021.2013375

108. Kellett S, Bennett D, Ryle T, Thake A. Cognitive analytic therapy for borderline personality disorder: therapist competence and therapeutic effectiveness in routine practice. Clin Psychol Psychother. 2013;20(3):216–225. doi:10.1002/cpp.796

109. Weiner E, McKay D. A preliminary evaluation of repeated exposure for depersonalization and derealization. Behav Modif. 2013;37(2):226–242. doi:10.1177/0145445512461651

110. Wildgoose A, Clarke S, Waller G. Treating personality fragmentation and dissociation in borderline personality disorder: a pilot study of the impact of cognitive analytic therapy. Br J Med Psychol. 2001;74(Pt 1):47–55. doi:10.1348/000711201160795

111. Bellino S, Paradiso E, Bogetto F. Efficacy and tolerability of aripiprazole augmentation in sertraline-resistant patients with borderline personality disorder. Psychiatry Res. 2008;161(2):206–212. doi:10.1016/j.psychres.2007.07.006

112. Bozzatello P, Rocca P, Uscinska M, Bellino S. Efficacy and tolerability of asenapine compared with olanzapine in borderline personality disorder: an open-label randomized controlled trial. CNS Drugs. 2017;31(9):809–819. doi:10.1007/s40263-017-0458-4

113. Davis LL, Jewell ME, Ambrose S, et al. A placebo-controlled study of nefazodone for the treatment of chronic posttraumatic stress disorder: a preliminary study. J Clin Psychopharmacol. 2004;24(3):291–297. doi:10.1097/01.jcp.0000125685.82219.1a

114. Hollander E, Liebowitz MR, DeCaria C, Fairbanks J, Fallon B, Klein DF. Treatment of depersonalization with serotonin reuptake blockers. J Clin Psychopharmacol. 1990;10(3):200–203. doi:10.1097/00004714-199006000-00008

115. Marshall RD, Lewis-Fernandez R, Blanco C, et al. A controlled trial of paroxetine for chronic PTSD, dissociation, and interpersonal problems in mostly minority adults. Depress Anxiety. 2007;24(2):77–84. doi:10.1002/da.20176

116. Marshall RD, Schneier FR, Fallon BA, et al. An open trial of paroxetine in patients with noncombat-related, chronic posttraumatic stress disorder. J Clin Psychopharmacol. 1998;18(1):10–18. doi:10.1097/00004714-199802000-00003

117. Nuller YL, Morozova MG, Kushnir ON, Hamper N. Effect of naloxone therapy on depersonalization: a pilot study. J Psychopharmacol. 2001;15(2):93–95. doi:10.1177/026988110101500205

118. Philipsen A, Richter H, Schmahl C, et al. Clonidine in acute aversive inner tension and self-injurious behavior in female patients with borderline personality disorder. J Clin Psychiatry. 2004;65(10):1414–1419. doi:10.4088/JCP.v65n1018

119. Philipsen A, Schmahl C, Lieb K. Naloxone in the treatment of acute dissociative states in female patients with borderline personality disorder. Pharmacopsychiatry. 2004;37(5):196–199. doi:10.1055/s-2004-827243

120. Roullet P, Taïb S, Thalamas C, et al. Efficacy of traumatic memory reactivation with or without propranolol in PTSD with high dissociative experiences. Eur J Psychotraumatol. 2022;13(2):2151098. doi:10.1080/20008066.2022.2151098

121. Schmahl C, Kleindienst N, Limberger M, et al. Evaluation of naltrexone for dissociative symptoms in borderline personality disorder. Int Clin Psychopharmacol. 2012;27(1):61–68. doi:10.1097/YIC.0b013e32834d0e50

122. Sierra M, Phillips ML, Ivin G, Krystal J, David AS. A placebo-controlled, cross-over trial of lamotrigine in depersonalization disorder. J Psychopharmacol. 2003;17(1):103–105. doi:10.1177/0269881103017001712

123. Sierra M, Baker D, Medford N, et al. Lamotrigine as an add-on treatment for depersonalization disorder: a retrospective study of 32 cases. Clin Neuropharmacol. 2006;29(5):253–258. doi:10.1097/01.WNF.0000228368.17970.DA

124. Simeon D, Guralnik O, Schmeidler J, Knutelska M. Fluoxetine therapy in depersonalisation disorder: randomised controlled trial. Br J Psychiatry. 2004;185:31–36. doi:10.1192/bjp.185.1.31

125. Simeon D, Knutelska M. An open trial of naltrexone in the treatment of depersonalization disorder. J Clin Psychopharmacol. 2005;25(3):267–270. doi:10.1097/01.jcp.0000162803.61700.4f

126. Uguz F, Sahingoz M. Aripiprazole in depersonalization disorder comorbid with major depression and obsessive-compulsive disorder: 3 cases. Clin Neuropharmacol. 2014;37(4):125–127. doi:10.1097/WNF.0000000000000036

127. Jay EL, Sierra M, Van den Eynde F, Rothwell JC, David AS. Testing a neurobiological model of depersonalization disorder using repetitive transcranial magnetic stimulation. Brain Stimul. 2014;7(2):252–259. doi:10.1016/j.brs.2013.12.002

128. Jay EL, Nestler S, Sierra M, McClelland J, Kekic M, David AS. Ventrolateral prefrontal cortex repetitive transcranial magnetic stimulation in the treatment of depersonalization disorder: a consecutive case series. Psychiatry Res. 2016;240:118–122. doi:10.1016/j.psychres.2016.04.027

129. Mantovani A, Simeon D, Urban N, Bulow P, Allart A, Lisanby S. Temporo-parietal junction stimulation in the treatment of depersonalization disorder. Psychiatry Res. 2011;186(1):138–140. doi:10.1016/j.psychres.2010.08.022

130. Atchley R, Bedford C. Dissociative symptoms in posttraumatic stress disorder: a systematic review. J Traum Dissoc. 2021;22(1):69–88. doi:10.1080/15299732.2020.1760410

131. Hoeboer CM, De Kleine RA, Molendijk ML, et al. Impact of dissociation on the effectiveness of psychotherapy for post-traumatic stress disorder: meta-analysis. BJPsych Open. 2020;6(3):e53. doi:10.1192/bjo.2020.30

132. Sutar R, Sahu S. Pharmacotherapy for dissociative disorders: a systematic review. Psychiatry Res. 2019;281:112529. doi:10.1016/j.psychres.2019.112529

133. Escamilla I, Juan N, Peñalva C, et al. Treatment of dissociative symptoms with opioid antagonists: a systematic review. Eur J Psychotraumatol. 2023;14(2):2265184. doi:10.1080/20008066.2023.2265184

134. Solmi M, Murru A, Pacchiarotti I, et al. Safety, tolerability, and risks associated with first-and second-generation antipsychotics: a state-of-The-art clinical review. Therapeut Clinical Risk Manag. 2017;29:757–777. doi:10.2147/TCRM.S117321

135. MacNamara A, Rabinak CA, Kennedy AE, et al. Emotion regulatory brain function and SSRI Treatment in PTSD: neural correlates and predictors of change. Neuropsychopharmacology. 2016;41(2):611–618. doi:10.1038/npp.2015.190

136. Quentin E, Belmer A, Maroteaux L. Somato-dendritic regulation of raphe serotonin neurons; a key to antidepressant action. Front Neurosci. 2018;12:982. doi:10.3389/fnins.2018.00982

137. Maier SF, Seligman MEP. Learned helplessness at fifty: insights from neuroscience. Psychol Rev. 2016;123(4):349–367. doi:10.1037/rev0000033

138. Brandão ML, Lovick TA. Role of the dorsal periaqueductal gray in posttraumatic stress disorder: mediation by dopamine and neurokinin. Transl Psychiatry. 2019;9(1):232. doi:10.1038/s41398-019-0565-8

139. Vázquez-León P, Miranda-Páez A, Valencia-Flores K, Sánchez-Castillo H. Defensive and emotional behavior modulation by serotonin in the periaqueductal gray. Cell Mol Neurobiol. 2023;43(4):1453–1468. doi:10.1007/s10571-022-01262-z

140. Tiwari P, Berghella AP, Sayalı C, Doss MK, Barrett FS, Yaden DB. Learned helplessness as a potential transdiagnostic therapeutic mechanism of classic psychedelics. Psychedelic Med. 2023;1(2):74–86. doi:10.1089/psymed.2023.0010

141. Green WM, Raut SB, James FLJ, Benedek DM, Ursano RJ, Johnson LR. MDMA assisted psychotherapy decreases PTSD symptoms, dissociation, functional disability, and depression: a systematic review and meta-analysis; 2023.

142. Kim HK, Blumberger DM, Downar J, Daskalakis ZJ. Systematic review of biological markers of therapeutic repetitive transcranial magnetic stimulation in neurological and psychiatric disorders. Clin Neurophysiol. 2021;132(2):429–448. doi:10.1016/j.clinph.2020.11.025

143. Wilterson AI, Nastase SA, Bio BJ, Guterstam A, Graziano MSA. Attention, awareness, and the right temporoparietal junction. Proc Natl Acad Sci U S A. 2021;118(25):e2026099118. doi:10.1073/pnas.2026099118

144. Murray RJ, Debbané M, Fox PT, Bzdok D, Eickhoff SB. Functional connectivity mapping of regions associated with self- and other-processing. Hum Brain Mapp. 2015;36:1304–1324. doi:10.1002/hbm.22703

145. Dixon ML, Thiruchselvam R, Todd R, Christoff K. Emotion and the prefrontal cortex: an integrative review. Psychol Bull. 2017;143(10):1033–1081. doi:10.1037/bul0000096

146. Mo L, Li S, Cheng S, Li Y, Xu F, Zhang D. Emotion regulation of social pain: double dissociation of lateral prefrontal cortices supporting reappraisal and distraction. Soc Cognit Affective Neurosci. 2023;18(1). doi:10.1093/scan/nsad043

147. Baer R, Crane C, Miller E, Kuyken W. Doing no harm in mindfulness-based programs: conceptual issues and empirical findings. Clin Psychol Rev. 2019;71:101–114. doi:10.1016/j.cpr.2019.01.001

148. Farias M, Maraldi E, Wallenkampf KC, Lucchetti G. Adverse events in meditation practices and meditation-based therapies: a systematic review. Acta Psychiatr Scand. 2020;142(5):374–393. doi:10.1111/acps.13225

149. Ardito RB, Rabellino D. Therapeutic alliance and outcome of psychotherapy: historical excursus, measurements, and prospects for research. Front Psychol. 2011;2:270. doi:10.3389/fpsyg.2011.00270

150. Kearney BE, Corrigan FM, Frewen PA, et al. A randomized controlled trial of Deep Brain Reorienting: a neuroscientifically guided treatment for post-traumatic stress disorder. Europ J Psychotraumatol. 2023;14(2):2240691. doi:10.1080/20008066.2023.2240691

Creative Commons License © 2024 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.